Medical News

RSS

Tyco signs definitive agreement to sell South Korean security business to The Carlyle Group

Tyco today announced that it has signed a definitive agreement to sell Tyco Fire & Security Services Korea Co. Ltd. and its subsidiaries (ADT Caps Co., Ltd., Capstec Co., Ltd. and ADT Security Co., Ltd.) that form and operate the Company's South Korean security business ("ADT Korea") to The Carlyle Group, in a cash transaction valued at approximately $1.93 billion.

3 Mar 2014

New article explores risks associated with using herbal cannabis for rheumatic conditions

Patients with rheumatic conditions are in need of symptom relief and some are turning to herbal cannabis as a treatment option. However, the effectiveness and safety of medical marijuana to treat symptoms of rheumatic conditions such as rheumatoid arthritis, lupus, or fibromyalgia is not supported by medical evidence. A new article published in Arthritis Care & Research, a journal of the American College of Rheumatology, explores the risks associated with using herbal cannabis for medicinal purposes and advises healthcare providers to discourage rheumatology patients from using this drug as therapy.

3 Mar 2014

Akorn's consolidated revenue for fourth quarter 2013 increases 19% to $85 million

Akorn, Inc., a niche generic pharmaceutical company, today reported financial results for the fourth quarter and year-ended December 31, 2013.

3 Mar 2014

Doctors offer ways to help protect kidneys

The kidneys, two very important organs located in your back, help to continuously clean out wastes and extra fluid from your body. One in 10 Americans develops kidney disease due to diabetes, high blood pressure or a family history of kidney failure.

3 Mar 2014

Georgia hospital places order for Mazor Robotics' Renaissance system

Mazor Robotics Ltd., a developer of innovative guidance systems and complementary products, announced today that a hospital in Georgia, USA placed an order for its first Renaissance system.

3 Mar 2014

Magellan Health Services reports net revenue of $3.5 billion for fourth quarter 2013

Magellan Health Services, Inc. today reported financial results for the fourth quarter and full year 2013, as summarized below.

3 Mar 2014

Insurers gather new customers' health information -- a critical step in calculating prices for next year's plans offered on exchanges

Meanwhile, Reuters reports that chronically ill consumers who obtain coverage from the online insurance marketplaces may still face high drug costs despite the health law's ban on discriminatory insurance practices. Also, news outlets report on Time magazine's cover story that details how the Obama administration almost shutdown healthcare.gov during its early, fitful days.

3 Mar 2014

Bayer Yakuhin submits marketing authorization application in Japan for EYLEA Injection

Regeneron Pharmaceuticals, Inc. today announced that Bayer HealthCare's Japanese subsidiary, Bayer Yakuhin, Ltd., has submitted an application for marketing authorization for EYLEA (aflibercept) Injection for the treatment of patients with diabetic macular edema (DME) to the Japanese Ministry of Health, Labour and Welfare.

3 Mar 2014

ClearWay Minnesota launches new version of QUITPLAN Services for Minnesotans

ClearWay Minnesota launched a new version of QUITPLAN Services, the free cessation program available to any Minnesotan who wants to quit tobacco. The new services now include free access to text messages, email support, a downloadable quit guide and free "starter kits," which provide a two-week supply of nicotine patches, gum or lozenges to help tobacco users quit.

3 Mar 2014

First Edition: March 3, 2014

Today's headlins include stories detailing ongoing challenges with state-run exchanges as well as previews of what's next regarding the federal budget process.

3 Mar 2014

New molecule fluorogenic probe for rapid assessment of individual's risk for Parkinson's disease

A team of researchers from National University of Singapore (NUS) have created the first two-photon, small molecule fluorogenic probe that can serve as a useful tool for the rapid assessment of an individual's potential risk for Parkinson's disease.

3 Mar 2014

Atopix presents positive results of Phase IIb asthma study at AAAAI meeting

Atopix Therapeutics Ltd ("Atopix"), a biopharmaceutical company developing innovative CRTH2 antagonists for allergic disease, announced the results of a Phase IIb asthma study with their lead compound OC459 at the American Academy of Allergy, Asthma and Immunology (AAAAI) Annual Meeting , San Diego, California, USA on March 1st.

3 Mar 2014

Research roundup: Medicaid peer support; doctor Jokes; ACA's asset rules for coverage

Since 2009, the eight states (Alabama, Illinois, Louisiana, Massachusetts, New York, Utah, Virginia, and Wisconsin) participating in the Robert Wood Johnson Foundation's Maximizing Enrollment program have worked to streamline and simplify enrollment systems, policies, and processes for children and those eligible for coverage in 2014. ... States [focused] on five key areas: 1) applications, 2) eligibility determinations, 3) renewals and transfers, 4) notices, and 5) business processes.

3 Mar 2014

Roark Capital Group invests in Anytime Fitness

Anytime Fitness, the world's largest and fastest-growing co-ed fitness franchise, today announced that an affiliate of Roark Capital Group, an Atlanta-based private equity firm that focuses on investing in the franchise industry, has made an equity investment in the company.

3 Mar 2014

AACR to showcase latest breakthroughs in cancer research

The American Association for Cancer Research (AACR) will showcase newsworthy research on clinical trials, epidemiology, immunology, epigenetics, laboratory science, and translational medicine at its Annual Meeting, April 5-9.

3 Mar 2014

Many children admitted with mental health problems mistaken for physical disease

Many children are admitted to general acute wards with mental health problems mistaken for physical disease.

3 Mar 2014

Five women scientists to receive ‘L’Oréal-UNESCO For Women in Science Awards'

On March 19th the L'Oréal Foundation and UNESCO will present the L'Oréal-UNESCO For Women in Science awards to five outstanding women scientists.

3 Mar 2014

ASN to conduct Scientific Sessions and Annual Meeting at Experimental Biology in San Diego

The American Society for Nutrition (ASN) will hold its 2014 Scientific Sessions and Annual Meeting at Experimental Biology (EB), from April 26-30, 2014, in San Diego. EB 2014 brings together the leading researchers from dozens of life-science disciplines.

3 Mar 2014

RainDance Technologies closes $16.5 million Series E financing round

RainDance Technologies, Inc., an innovative genomics tools company making molecular testing of complex diseases more standardized and readily available, today announced that it has closed a $16.5 million Series E financing round extension. New investors include GE Ventures and Northgate Capital; all existing financial investors also participated in this round of financing.

3 Mar 2014

Exercising during pregnancy prevents weight gain and illness

Excessive weight gain during pregnancy increases the risk of suffering illnesses such as hypertension and gestational diabetes, or of having a premature birth or a birth by Caesarean; furthermore, it also has negative effects on the newly-born and increases the risk of infants being overweight by 30%.

3 Mar 2014

Medical News

Tyco signs definitive agreement to sell South Korean security business to The Carlyle Group

New article explores risks associated with using herbal cannabis for rheumatic conditions

Akorn's consolidated revenue for fourth quarter 2013 increases 19% to $85 million

Doctors offer ways to help protect kidneys

Georgia hospital places order for Mazor Robotics' Renaissance system

Magellan Health Services reports net revenue of $3.5 billion for fourth quarter 2013

Insurers gather new customers' health information -- a critical step in calculating prices for next year's plans offered on exchanges

Bayer Yakuhin submits marketing authorization application in Japan for EYLEA Injection

ClearWay Minnesota launches new version of QUITPLAN Services for Minnesotans

First Edition: March 3, 2014

New molecule fluorogenic probe for rapid assessment of individual's risk for Parkinson's disease

Atopix presents positive results of Phase IIb asthma study at AAAAI meeting

Research roundup: Medicaid peer support; doctor Jokes; ACA's asset rules for coverage

Roark Capital Group invests in Anytime Fitness

AACR to showcase latest breakthroughs in cancer research

Many children admitted with mental health problems mistaken for physical disease

Five women scientists to receive ‘L’Oréal-UNESCO For Women in Science Awards'

ASN to conduct Scientific Sessions and Annual Meeting at Experimental Biology in San Diego

RainDance Technologies closes $16.5 million Series E financing round

Exercising during pregnancy prevents weight gain and illness

Directed enzyme evolution and the Nobel Prize: Making enzymes evolve in the lab

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Latest News